Navigation Links
MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products
Date:12/16/2009

WILMINGTON, Delaware, December 16 /PRNewswire/ -- While many of the pharma companies are struggling to outsource their accurate forecast models for new and inmarket drugs, MarketsandMarkets on the other hand provides integrated patient-based forecast solutions to various players. These pharma forecasting solutions are designed for phase I, phase II, as well as phase III. These have a substantial impact on pricing, launch, product life cycle management, market entry strategy, manufacturing planning, sales force, promotion, and planning. The leading pharma companies now endorse the forecast solution provided by MarketsandMarkets as the accurate forecast model, comprising of significant cost benefit analysis for an annual contract basis. The forecasts are based on epidemiology and actual patients on drugs. The primary and secondary research analytics underlying the forecast include:

    - Epidemiology analysis
    - Treated patients best fit trending
    - Polypharmacy ratio analysis
    - Competitive landscape analysis
    - Analogue analysis for uptake, time to peak, and generic erosion
    - Conjoint / discrete choice / attribute analysis
    - Calibration based on actual sales and impact of various events

The treated patient pool potential is determined by prevalence, incidence, diagnosis, treatment, cure, and mortality rate. The treated patient pool is also back-calculated simultaneously from historic and present product sales. Trending and smoothening takes into account seasonality and the impact of other events on sale. The conjoint / discrete choice analysis uses primary research to estimate peak patient share for new products. In absence of primary research due to budget / time constraints, an attribute analysis is done using secondary research and consumer inputs to estimate peak patient share for new products.

The peak patient share calculation mechanism is calibrated based on shares of existing products. Ratio of treated patient pool, based on patient on products and epi, gives polypharmacy ratio. Analogues are identified based on disease area, TPP, MoA, order of entry, and market dynamics to estimate time to peak, shape of uptake curve, generic erosion, and impact of other events. Share exchange / cannibalization is done based on fair-share approach or inputs from brand team along with secondary and primary research.

Simple and transparent VB- and Excel-based forecast models: models are developed based on forecast complexity and the functional need of end-user. Our team has expertise in designing and developing VB- and Excel-based forecast / market models.

Strong quality checks: - quality checks are built up at each stage to ensure foolproof estimates, including triangulation of epi data from multiple sources, calibration based on polypharmacy and actual historic sale, calibration of peak patient share estimation model or peak patient share based on share. Quality checks embedded in the Excel / VB formula in the forecast model.

We have strong team of analysts with experience in executing advanced forecasting projects for both pipeline and in-market products for the top pharma companies globally.

    For more details, click on:
http://www.marketsandmarkets.com/patient-based-forecasting.asp

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.

    Contact:
    Ms. Sunita
    108, West 13th Street,
    Wilmington, DE, 19801
    County of New Castle
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com


SOURCE MarketsandMarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014
2. MarketsandMarkets: Global Home health Care Market Worth US$159.6 Billion by 2014
3. MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014
4. MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014
5. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014
6. Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential
7. EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content
8. InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery
9. Amedisys Selects MetricStream for Integrated Enterprise-wide GRC
10. Health Integrated Announces Turnkey Model of Care Program for Special Needs Health Plans
11. Glide Health Corporation and Integrated Medical Professionals Announce Partnership to Deploy the Glide Mobile Health Platform to Over One Million Patients and Over 100 Physicians in 50 Locations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: